Rapid-Onset Psychotic Symptoms After Interferon-β-1a Treatment of Multiple Sclerosis

被引：0
|
作者：
Huang, Jing-Syuan [1 ,2 ]
Chang, Chuan-Chia [2 ]
Tai, Yueh-Ming [1 ,2 ]
Huang, Chien-Peng [3 ]
Chen, Shyi-Jou [4 ]
Tzeng, Nian-Sheng [2 ,5 ]
机构：
[1] Triserv Gen Hosp, Natl Def Med Ctr, Beitou Branch, Dept Psychiat, Taipei, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan
[3] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pathol, Taipei, Taiwan
[4] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pediat, Taipei, Taiwan
[5] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2020年 / 27卷 / 06期
关键词：
IFN-BETA-1A; THERAPY; PATIENT;
D O I：
10.1097/MJT.0000000000001017
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：E627 / E629
页数：4
相关论文
共 50 条
  • [41] Quality of life in multiple sclerosis:: comparison after one year of tratment with interferon-β-1a and 1b
    Mendes, MF
    Tilbery, CP
    Oliveira, BS
    Kelian, GL
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S251 - S251
  • [42] Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis
    Yamaguchi, Hiroki
    Sakai, Kenji
    Goto, Yoshinori
    Yamada, Masahito
    JOURNAL OF NEUROLOGY, 2018, 265 (06) : 1469 - 1471
  • [43] Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis
    Hiroki Yamaguchi
    Kenji Sakai
    Yoshinori Goto
    Masahito Yamada
    Journal of Neurology, 2018, 265 : 1469 - 1471
  • [44] The effect of interferon-β-1a on magnetisation transfer ratio in primary progressive multiple sclerosis
    Leary, SM
    Traboulsee, A
    Miller, DH
    Thompson, AJ
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 : S243 - S244
  • [45] Migration of T-cell subsets in multiple sclerosis and the effect of interferon-β1a
    Dressel, A.
    Mirowska-Guzel, D.
    Gerlach, C.
    Weber, F.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (03): : 164 - 168
  • [46] Safety and efficacy of combination therapy with interferon-β-1a and methotrexate in worsening multiple sclerosis
    Gharagozli, K
    Fallahi, F
    Mohammadi, MM
    Zadeh, MM
    Abdoli, N
    Abadian, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S263 - S263
  • [47] Ongoing efficacy and safety analysis of interferon-β1a (AVONEX) in patients with multiple sclerosis
    Herndon, RM
    Coats, M
    Goodkin, D
    Mass, M
    Richert, J
    Rudick, RA
    Weinstock-Guttman, B
    Simonian, NA
    Campion, M
    Scaramocci, J
    Alam, JJ
    Jacobs, LD
    ANNALS OF NEUROLOGY, 1997, 42 (06) : 987 - 987
  • [48] Differential immunomodulatory effects of interferon-β1a/1b in patients with multiple sclerosis
    Papachroni, K.
    Fragoulis, N.
    Piperi, C.
    Patrikiou, A.
    Papadimitriou, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [49] Rhabdomyolysis during interferon-β 1a treatment
    Lünemann, JD
    Kassim, N
    Zschenderlein, R
    Zipp, F
    Schwarzenberger, B
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (02): : 274 - 274
  • [50] Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results
    A. Ghezzi
    M. P. Amato
    M. Capobianco
    P. Gallo
    M. G. Marrosu
    V. Martinelli
    C. Milanese
    L. Moiola
    N. Milani
    L. La Mantia
    F. Patti
    C. Pozzilli
    M. Trojano
    G. Comi
    M. Zaffaroni
    Neurological Sciences, 2007, 28 : 127 - 132
12345